Ikarian Capital, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$794,000
-87.6%
702,773
-67.1%
0.14%
-82.7%
Q1 2022$6,390,000
+449.0%
2,137,128
+386.4%
0.84%
+385.5%
Q4 2021$1,164,000
-3.7%
439,356
+27.2%
0.17%
+226.4%
Q4 2020$1,209,000
-27.5%
345,529
-50.3%
0.05%
-56.2%
Q3 2020$1,668,000
-45.8%
695,529
-58.6%
0.12%
-50.6%
Q2 2020$3,075,000
+17.3%
1,680,5290.0%0.24%
+24.4%
Q1 2020$2,622,000
+250.1%
1,680,529
+380.2%
0.20%
+62.8%
Q4 2019$749,000350,0000.12%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders